Background: Gestational diabetes mellitus (GDM) is defined as glucose intolerance with first dignosis during pregnancy. There is some evidence indicating that chemerin play a role in the development of GDM. In this study, for the first time, a possible association of rs17173608 polymorphism in the chemerin gene with the risk of GDM in Arak population was investigated.

Materials and Methods: In this case-control study, 120 GDM and 150 pregnant women with normal glucose tolerance were selected. GDM was confirmed by oral glucose tolerance according to the new IADPSG criteria. Genomic DNA was extracted from EDTA treated whole blood. The polymorphism of chemerin gene was determined using tetra-amplification refractory mutation system-polymerase chain reaction (T-ARMS-PCR).

Results: The genotype frequencies of  TT, GT and GG at rs17173608 were respectively 81.7%, 17.5% and 0.8% in the GDM group and 73.3%, 25.3% and 1.3% in the control group. There were no statistical differences in genotype frequencies between case group and the control group. Also, allele frequencies in the GDM group  (T 90.4% , G 9.6%), did not differ significantly from the control group ( T 96% ,G 14%). No association was found between genotype frequencies and FBS, 1h, 2 h and BMI.

Conclusion: The present study show that the rs17173608 polymorphism in the chemerin gene is not associated with the development of glucose intolerance and GDM in the studied population.

Background: Breast cancer is one of the major causes of cancer-related death and the most common solid malignancy in women worldwide. Chemerin as a new adipokine has an inflammatory activity that initiates inflammation via chemotaxis of immature DCs and macrophages. This study aimed to evaluate the level of chemerin in patients with breast cancer.

Materials and Methods: In this cross-sectional study that was performed as a case-control study, we enrolled 45 patients with breast cancer in Vali-asr hospital from June to December 2015 (age range, 18-60 years) and 40 healthy volunteers as a control group (age range, 22-56 years). The patients with invasive breast were selected before mastectomy. The level of serum chemerin was measured by ELISA kit.

Results: The results showed that the mean serum chemerin level in the breast cancer patients (1536 ±608 ng/L) was significantly lower than the normal individuals (1919±544 ng/L),(p=0.04). There is no correlation between the level of chemerin with body weight, stage of disease, duration of disease and the number of white and red blood cells.

Conclusion: With due attention to the inflammatory role of chemerin, decreasing the serum chemerin level in patients with breast cancer may be related to the consumption of chemerin in the inflammatory responses or immunosuppression by tumor. The low level of chemrerin may be suitable for tumor growth and progression.

Abstract

Background: The prevalence of obesity among children is alarmingly rising. Obesity in a chronical inflammatory condition accompanies with inflammatory markers such as Chemerin and CRP; therefore, the aim of this following study is to compare the affection of Endurance & High Intensity Interval Trainings on levels of Chemerin & Protein of C-reactive plasma in obese children.

Materials and Methods: This experimentation included 21 obese children (average weight 61.46±2.5 kg and BMI 7.1±4.31) aging 9-12 years old who were randomly divided into three groups of endurance, HIIT and control (n=7). The training groups performed regular exercises for 8 weeks long (3 sessions in every week). The differences between groups were evaluated using covariance analysis. (p<0.05).

Results: In both training groups, there was a more significant decrease in weight, BMI and body fat percentage than there was before workouts. In HIIT group, we witnessed a significant reduction in level of Chemerin (p=0.016) than before. CRP level was also decreased in both groups, but the changes were not significant.

Conclusion: In summary, 8 weeks of HIIT exercises compared to endurance trainings have greater effect on Chemerin and CRP levels in obese children.